Claritas Rx Introduces Consent Clearinghouse™ to Modernize Patient Consent Management Across Biopharma
New Solution Gives Oncology and Rare Disease Teams a Centralized, Compliant View of Patient Consent Across the Full Therapy Journey
New White Paper from Claritas Rx Entitled “Why Consent Management is Biopharma’s Blind Spot” Now Available
Claritas Rx, the patient journey experts, today announced Consent Clearinghouse™, a dedicated solution for standardizing and centralizing patient consent across oncology, rare disease, and specialty biopharma.
As biopharma companies navigate an increasingly complex regulatory environment, including HIPAA, GDPR, CCPA, a growing patchwork of state privacy laws, and the emerging rules governing the use of AI, managing patient consent across multiple data sources, specialty pharmacies, hubs, and channel partners has become a critical operational and compliance challenge. Consent Clearinghouse addresses this directly by providing a single, auditable source of truth for consent data across all touchpoints.
